Espinoza Octavio sold LGND
March 4, 2025 · Form 4 insider transaction
Espinoza Octavio sold 5,000 shares of Ligand Pharmaceuticals Incorporated at $115.03 per share, a transaction worth $575.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,000
Price
$115.03
Total value
$575.1K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 4, 2025
Filing dateMarch 6, 2025
Shares owned after18,879
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.8900 to $115.1850, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.